abe MicroRNAs (miRNAs) are a class of short noncoding RNAs which are endogenously expressed in many organisms and regulate gene expression by binding to messenger RNA (mRNA). MicroRNAs are either produced from their independent transcription units in intergenic regions or lie in intragenic regions.
Introduction
MicroRNAs function as a fundamental layer of post-transcriptional regulation of gene expression by binding to approximately 20 nucleotide long, 1 partially complementary, microRNA target sites typically present in the 3 0 -untranslated region (UTR) of a target mRNA. 2, 3 The RNA-induced silencing complex (RISC) facilitates miRNA binding and leads to translation inhibition or mRNA degradation and cleavage. 4, 5 Mapping of miRNA locations in the genome has revealed the presence of miRNA in either intergenic or intragenic regions. [6] [7] [8] Intergenic miRNAs are autonomous transcription units while intragenic miRNAs are transcribed together with protein coding genes 7, 9, 10 and can be physically located in the intron, exon, or UTR of the host gene. 11 Intragenic miRNAs interface with the cellular environment by regulating several genes simultaneously. Notably, these genes are often important to the immediate interaction network of the host gene. 6 The regulation of the host mRNA by the microRNA can be indirect (e.g. by targeting a transcription factor of the host transcript 12 ) or direct, forming an incoherent feedforward loop architecture. 13 Today, there are open questions regarding the timing and efficiency of the splicing of the introns by the spliceosome, the processing of the miRNA by the microprocessor, and the associated implications for the miRNA function and mRNA stability. 14, 15 Possible scenarios 16 for the miRNA microprocessor and spliceosome activities include that the spliceosome and microprocessor work independent of each other, that the spliceosome and microprocessor work together and have a cooperative relationship, and finally that the spliceosome and microprocessor mutually inhibit each other. Experimental results [17] [18] [19] [20] suggest a mutually cooperative, physical, and functional coupling of intronic microRNA biogenesis and splicing at the host intron, but importantly warrant additional synthetic biology-inspired experimentation towards rational engineering of intragenic transcripts. Here we use custom intragenic miRNAs as a method for combined gene and functional miRNA/RNA delivery. Specifically, we engineer and study in mammalian cells a range of synthetic intragenic miRNAs co-expressed with their host genes. Our long-term objective is to harness the properties of these transcripts for custom combined delivery 21 and implementation of complex circuits.
Results and discussion
To probe the intragenic miRNA biogenesis and pre-mRNA splicing crosstalk, and towards combined delivery of miRNA and protein, we engineered a range of constructs that contain a synthetic miRNA (namely miRNA-FF3 13, 23, 24 ) and an mRNA (with and without the miRNA target) coding for the fluorescent protein dsRedExpress (we will refer to it as dsRed). The intragenic miRNA and host mRNA (dsRed) transcript is controlled by an inducible bidirectional promoter which divergently transcribes an amCyan fluorescent protein (Fig. 1a) 25 We engineered synthetic splice sites to flank a synthetic miRNA. Furthermore, we built constructs with UTR miRNAs without splice sites to nullify the effect of the spliceosome and study the independent effect of the microprocessor on the mRNA transcript. Finally, we designed control transcripts with mutant miRNAs to abolish the effect of the microprocessor.
As illustrated in Fig. 1b As a backbone for the transcripts, we used the plasmid pTRE-Tight-Bi (Clontech) which contains a bidirectional pTRE-Tight promoter consisting of seven rtTA binding sites flanked by diverging minimal CMV promoters (CMV MIN ) and dsRed and amCyan on either side of the promoter. We use rtTA-expressing HEK293 TET-On cells with saturating Doxycycline (Dox) concentration, effectively turning the pTRE-Tight into a constitutive promoter (ESI, † Fig. S1 ). We transiently transfected HEK293 Tet-On cells using Lipofectamine LTX and assayed the output 48 hours post-transfection using microscopy and flow cytometry (FACS). A typical experiment using the fully induced promoter is illustrated in Fig. 1c , where we present a flow cytometry scatter plot of amCyan versus dsRed fluoroscence and representative microscopy images of each channel.
We first examined the expression of the host mRNA when we permutated the synthetic miRNA with the artificial splice sites ( (c) Representative microscopy and flow cytometry data of a control plasmid (without miRNA target).
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View Article Online the transfection efficiency) we observe an increase in expression correlated with the distance from the transcription start site (Fig. 2c) . In particular, the normalized expression of dsRed for the 3 0 -UTR case is higher than the intronic and both are higher than the 5 0 -UTR case. When we examine the transcripts with miRNA target (Fig. 2c) , we observe in all cases the microRNAs reduce the dsRed level to approximately the same level. In Fig. 2d , we provide representative microscopy snapshots of the amCyan and dsRed for all cases. From this set of initial experiments we arrive to a number of observations. If the spliceosome and microprocessor work exclusively together as a complex and assuming that it takes the same time for the complex to splice and produce the functional miRNA for all miRNA locations, then one would expect (approximately) the same expression level for all three constructs-a hypothesis refuted by the experiments. The increase in the yield (or efficiency) as the location of the miRNA insert changes from the 5 0 -to the 3 0 -UTR is possibly the result of a combined processing of the transcript by the spliceosome and microprocessor complex and stand-alone microprocessor units. Compared to spliceosome which is a megacomplex, 26 the microprocessor is essentially a two protein complex; 14, 27 therefore it is conceivable that the spliceosome may inhibit the microprocessor function but not vice versa. We can also assume that the spliceosome-microprocessor complex requires more time to process an intron carrying miRNA versus processing a non-miRNA coding intron. Considering the above, one potential explanation for the observed differential expression is that single 
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microprocessor units remove the microRNA prior to processing by the spliceosome-microprocessor complex.
To shed additional light to the process, we introduced introns with mutated miRNA into the untranslated regions and between the dsRed exons. To mutate the miRNA, the 22nt sequence involved in the stem loop formation was deleted and a random sequence was inserted which does not form a stem loop (ESI †). Comparing the expression of dsRed (Fig. 3a  and b) , we observe similar expression for the wild-type and 3 0 -UTR transcripts. Interestingly the 5 0 -UTR miRNA mutant results in low dsRed expression compared with 5 0 -UTR miRNA without mutations ( Fig. 2c and 3c) , which suggests the function of the microprocessor assists the spliceosome in the 5 0 -modifications. Again, in Fig. 3d , we provide representative microscopy snapshots of the amCyan and dsRed for all cases. For all cases with splice sites there is strong expression of dsRed protein and the miRNA is always functional (Fig. 2c) , which suggests that when the spliceosome operates on splice sites there is always microprocessing of the miRNAs. To establish that the microprocessor can work independently of the spliceosome, we removed the splice signals from the microRNA intron of the 3 0 -and 5 0 -UTR with splice sites constructs. The flow cytometry data (Fig. 4a ) and representative microscopy snapshots (Fig. 4b) show that for both cases there is production 
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View Article Online of dsRed but the behavior of the two transcripts is considerably different. More specifically, the dsRed expression is weak for the 5 0 -UTR transcript (Fig. 4c) . Furthermore, we observe that microRNA is processed correctly and efficiently in both transcripts, as judged by the transcripts with the miRNA target ( Fig. 4a and c) , and control experiments where we cotransfected the 5 0 -UTR transcript with a reporter protein carrying the miRNA target (ESI, † Fig. S2 ). For both 5 0 -and 3 0 -UTR cases, the microprocessor efficiently crops the miRNA. This confirms that the microprocessor can work independently from the spliceosome. We observe low levels of dsRed for the 5 0 -UTR transcript without splice sites.
Our hypothesis is that the microprocessor acts on the transcript and cleaves the miRNA before the end of transcription and the majority of the transcripts are consequently degraded. In the case of 3 0 -UTR without splice sites, the microprocessor cleaves the microRNA shortly before the end of the transcription and the transcripts are transferred immediately for further processing (3 0 -polyadenylation) salvaging the dsRed expression.
Furthermore, we observe (Fig. 4a ) that in the 5 0 -UTR case there is dsRed expression only for high amCyan levels (which indicates high copy-number transfected cells). We hypothesize that when the transcribed mRNA units exceed the free microprocessor copies then the transcripts can escape the microprocessor processing and are transferred to the cytoplasm with the microRNA as part of their UTR. In order to further examine the microprocessor saturation hypothesis we transfected variable amounts of the 5 0 -UTR transcript, and indeed we observe (Fig. 4e ) that for low concentrations the vast majority of the cells show negligible dsRed expression levels which gradually increases as we increase the concentration of the transfected plasmid. To confirm that the low expression of dsRed is due to cropping of the microRNA by the microprocessor we performed a control experiment, where we inserted the mutant microRNA without splice sites at the 5 0 -UTR. The expression of this construct is significantly higher than the 5 0 -microRNA (ESI, † Fig. S3 ) which suggests that the stability of the mRNA is not compromised exclusively by the sequence insertion. Therefore, the above experimental evidence suggests that the 5 0 -UTR transcript without splice sites operates as a thresholding device, which can be used to efficiently deliver functional miRNAs but restrict the protein production only to the highcopy transfected cells.
Conclusion
We use synthetic biology to study intragenic miRNAs as a means for combined gene and functional miRNA delivery. We engineered a range of transcripts carrying synthetic miRNAs co-expressed with their host genes. Our experiments confirm a synergistic relationship between the spliceosome and 
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microprocessor complex and provide proof that the microprocessor units operate independently of the spliceosome. From a synthetic biology perspective, our results show that the transcripts with the microRNA intron between protein coding exons result in intermediate expression levels while the 3 0 -UTR with a splice sites transcript yields the most efficient combined microRNA and protein delivery. Furthermore, the insertion of microRNAs in the 5 0 -UTR without splice sites can be used to restrict protein delivery only to high-copy transfected cells while the intragenic miRNA remains functional for all transfected cells. In summary, our results highlight the complex and dynamic interplay between the RNA processing events and point to opportunities for rational engineering of these transcripts for custom combined delivery and use in sophisticated circuits.
Methods

Recombinant DNA cloning
The restriction enzymes, Taq polymerase, and T4 ligase enzyme used for cloning and ligation were obtained from NEB. QIAGEN Plasmid isolation, gel extraction and PCR purification kits were used. For transformation, competent DH5a cells (originally obtained from Life Technologies) were prepared using the standard CaCl 2 method of competent cell preparation. Bacterial culture media and agar (BD Biosciences) were prepared according to manufacturer's instructions. Primers for all the experiments were designed using A Plasmid Editor (Ape -version 1.17) and synthesized from IDT and Sigma. The primers received were diluted into stocks of 100 pmol mL À1 . Sequencing was performed by Genewiz.
Cell culture
HEK293 TET-On Advanced cell line (Clontech, Cat-No#630931) was used in all the experiments. These cells are derived from human embryonic kidney cells. The cells were grown at 37 1C, 100% humidity and 5% CO 2 , in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Cat-No#11965-118) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Cat-No#26140-079), 0.1 mM non-essential amino acids (Invitrogen, Cat-No#11140-050), 0.045 mg mL À1 of penicillin and 0.045 mg mL À1 of streptomycin antibiotics (penicillin-streptomycin liquid, Invitrogen, Cat-No#15140-122) and sterilized using a filter (VWR, Cat-No#28199-778). The adherent culture was harvested from this medium by trypsinizing with trypsin-EDTA (0.25% trypsin with EDTA, Invitrogen Cat-No#25200-114) and diluting in a fresh medium upon reaching 50-90% confluence. In the tetracycline inducible expression (HEK293 TET-ON) system, the gene expression is turned on when Doxycycline (Dox, a derivative of tetracycline) is added to the culture medium. The critical component of the TET-ON system is the regulatory protein rtTA (reverse tetracycline controlled transactivator).
Transfection and data collection
1 40 000 cells in 1 mL of complete medium were plated into each well of 12 well plastic plates (Grenier Bio-one, Cat-No#665180) and grown for 24 hours. Lipofectamine LTX (Invitrogen, Cat-No#15338-100) was used for transient transfection according to the manufacturer's protocol. In short, the transfection mix was prepared by adding 200 ng of plasmids in 200 mL of DMEM for each well. 1.5 mL of Lipofectamine LTX was added to the mix and incubated at room temperature for 30 min. The transfection mix was then applied to the plates and mixed by gentle shaking. Dox induction was performed after 2 hours. The cells were incubated for about 48 hours before analysis.
Measurements
All the microscopy data were collected using an Olympus motorized inverted research microscope (IX81). All microscope images were taken from live cells grown in 12 well plates (CellStar, Cat-No. 665180) in the transfection medium supplemented with 10% FBS. The microscope is equipped with an environmental chamber (Weather station) held at 37 1C during measurements. The images were collected by a Hamamatsu camera at 10Â objective. The filter sets are as follows: 430/25Â (excitation) and 470/30 m (emission) for amCyan, and 565/55Â (excitation) and 650/70 (emission) for dsRed. The software used to analyze the microscopy data is Slidebook version 5.0. All the flow cytometry data were collected from a BD LSRFortessa cell analyzer. The cells were prepared for FACS analysis by trypsinizing each well with 0.1 mL 0.25% trypsin-EDTA, adding 0.5 mL DMEM media with FBS to neutralize the trypsin, collecting the cell suspension and centrifuging at 4000 rpm for 2 min. Medium was removed and the pellet re-suspended by short vortexing in 0.5 mL PBS buffer (Cellgro, Cat-No#45000-432). AmCyan was measured using a 200 nm laser and a 450/50 emission filter, the dsRed-monomer using a 300 nm laser and a 575/26 emission filter. The data from the FACS are analyzed using a software package called FlowJo.
